Research

August 23, 2011

Do you like this?

During a one-month period, about half of prescription drug ads failed to comply to at least one FDA rule and about a third were possibly non-adherent due to missing information, according to Dr. Deborah Korenstein and colleagues of Mount Sinai School of Medicine in New York.

Additionally, more than half failed to quantify serious risks.

The pharmaceutical industry currently enjoys a $58 billion marketing budget, while the FDA's division of drug marketing and advertising has significantly less and thus can't review every ad that gets published.

In an effort to augment its sparse budget, the agency has recently implemented the "Bad Ad" program, in which it asks physicians to report non-adherent or misleading ads. The FDA's guidelines, however, are subjective and challenging to enforce, and they don't emphasize transparency or include basic information relevant to prescribing.

Learn more from ABC News.

August 23, 2011

Latest Comments

  • Drug Ads

    FDA should ban all Ads for prescription drugs. Congress can help this by removing all tax advantages to the Pharmaceutical Companies for such Ads. Leave the choice of diagnosis and selection of appropriate medication to MDs who know what is good for the patient. Public should not be getting info on prescription drugs from glitzy Ads. There are MDs and Pharmacists to educate them as and when necessary.

    Posted by Lohit Tutupalli August 24, 2011 14:46:40

Add your thoughts

  

All comments are moderated and generally will be posted if they are on-topic and not abusive.

Industry Events

Search Events | Submit Yours

Built with Metro Publisher™